Sign in
BIOT Stock Price, Chart, Stats & News
L&G Pharma Breakthrough UCITS ETF
Save
L&G Pharma Breakthrough UCITS ETF (BIOT) does not currently pay a dividend.
Sector Equity Biotechnology
Category
0.49%
Expense ratio
–
Assets
18.87%
1Y return
BIOT chart
About
The L&G Pharma Breakthrough UCITS ETF is designed to mirror the financial performance generated by the Solactive Pharma Breakthrough Value Index.
Top 10 BIOT holdings
| Holding | Ownership |
|---|---|
Health care 2.71% | |
Health care 2.70% | |
Health care 2.69% | |
Health care 2.65% | |
Health care 2.60% | |
Health care 2.56% | |
Health care 2.54% | |
Health care 2.54% | |
Health care 2.52% | |
Health care 2.51% |
Similar securities
Based on sector and market capitalization
Report issue